Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?

Roberto Antonucci1, Paolo Contu, Annalisa Porcella

  • 1Neonatal Intensive Care Unit, University of Cagliari, Cagliari, Italy. roant@tiscalinet.it

Insights

Intrauterine smoke exposure may independently impact bronchopulmonary dysplasia (BPD) in very low birth weight infants. However, low gestational age, respiratory distress syndrome, and prolonged mechanical ventilation are the primary risk factors for BPD development.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Environmental Health

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
  • Identifying modifiable risk factors for BPD is crucial for improving infant outcomes.
  • Intrauterine smoke exposure is a potential environmental risk factor for respiratory diseases in neonates.

Purpose of the Study:

  • To investigate the association between intrauterine smoke exposure and the development of BPD in very low birth weight (VLBW) infants.
  • To identify key determinants of BPD in VLBW infants.

Main Methods:

  • A case-control study involving 277 VLBW infants (141 cases, 136 controls) who survived to discharge.
  • Retrospective data collection including parental interviews and clinical records.
  • Logistic regression analysis to assess the impact of variables such as gestational age, respiratory distress syndrome (RDS), mechanical ventilation (MV), patent ductus arteriosus (PDA), and intrauterine smoke exposure (ISE).

Main Results:

  • Gestational age < 30 weeks (GA<30), RDS, and prolonged mechanical ventilation (MV>7 days) were significantly associated with BPD.
  • Intrauterine smoke exposure (ISE) was not a significant factor when MV>7 was included in the model (OR 1.94).
  • Excluding MV>7, ISE showed a significant association with BPD (OR 2.21), alongside GA<30, RDS, and PDA.

Conclusions:

  • Low gestational age, RDS, and prolonged mechanical ventilation are major determinants of BPD.
  • Intrauterine smoke exposure appears to be an independent risk factor for BPD development in VLBW infants.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...